Polio eradication: inching forward, with safety nets

Affiliations

¹ Department of Medicine, Unit of Infectious Diseases and Vaccine Testing Center, University of Vermont College of Medicine, Burlington, VT 05405, USA. Electronic address: beth.kirkpatrick@med.uvm.edu.
² Department of Public Health Sciences, University of Virginia, Charlottesville VA, USA.

Comment

Beth D Kirkpatrick et al. Lancet Infect Dis. 2015 Nov.

. 2015 Nov;15(11):1244-5.

doi: 10.1016/S1473-3099(15)00261-3. Epub 2015 Aug 26.

¹ Department of Medicine, Unit of Infectious Diseases and Vaccine Testing Center, University of Vermont College of Medicine, Burlington, VT 05405, USA. Electronic address: beth.kirkpatrick@med.uvm.edu.
² Department of Public Health Sciences, University of Virginia, Charlottesville VA, USA.

No abstract available

Comment on

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, Oberste MS, Self S, Borate BR, Asturias EJ, Clemens R, Orenstein W, Jimeno J, Rüttimann R, Costa Clemens SA; Chilean IPV/bOPV study group. O'Ryan M, et al. Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26. Lancet Infect Dis. 2015. PMID: 26318714 Clinical Trial.